Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kwame Oteng Darko
Metformin and Gefitinib Cooperate to Inhibit Bladder Cancer Growth via Both AMPK and EGFR Pathways Joining at Akt and Erk
Scientific Reports
Multidisciplinary
Related publications
Dihydroartemisinin and Gefitinib Synergistically Inhibit NSCLC Cell Growth and Promote Apoptosis via the Akt/mTOR/Stat3 Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Linc01014 Regulates Gefitinib Resistance in Oesophagus Cancer via EGFR‐PI3K‐AKT‐mTOR Signalling Pathway
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
GDF15 Derived From Both Tumor-Associated Macrophages and Esophageal Squamous Cell Carcinomas Contributes to Tumor Progression via Akt and Erk Pathways
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
PLoS ONE
Multidisciplinary
Modulation of Gene Expression and Cell-Cycle Signaling Pathways by the EGFR Inhibitor Gefitinib (Iressa) in Rat Urinary Bladder Cancer
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Curcumin Attenuates Hyperglycemia-Driven EGF-induced Invasive and Migratory Abilities of Pancreatic Cancer via Suppression of the ERK and AKT Pathways
Oncology Reports
Medicine
Cancer Research
Oncology
Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
Frontiers in Oncology
Cancer Research
Oncology
Inactivation of Both FHIT and P53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway
Asian Pacific Journal of Cancer Prevention
